A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...

Kennedy Jr.'s installation atop the nation’s health bureaucracy. The Advisory Committee on Immunization Practices (ACIP) ...

A panel of experts advising the U.S. Centers for Disease Control and Prevention on vaccines will not convene for its February ...

Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90.

International biotechnology company GlaxoSmithKline is moving its vaccine and infectious disease research teams to Cambridge, ...

Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

The success of an ongoing pilot programme offering RSV vaccination to newborn infants provides hope in tackling the ...

BP is under siege from Elliott, arguably the world’s most feared activist hedge fund. So far, it’s a story largely confined ...

DelveInsight's Influenza Vaccine Market Insights report provides the current and forecast market analysis, individual leading ...

GSK (GSK) has agreed to sell 500K doses of its avian flu vaccine to Canada to protect the country's at-risk individuals and ...

Following similar deals in countries like the United States and the U.K., Canada is bolstering its stockpile of bird flu ...

Shares of GSK PLC GSK rose 1.79% to £14.47 Thursday, on what proved to be an all-around rough trading session for the stock ...